Stockscreener 앱 받기
3.14
2.48%
-0.08
시간 외 거래:
3.15
0.010
+0.32%
전일 마감가:
$3.22
열려 있는:
$3.24
하루 거래량:
1.23M
Relative Volume:
1.71
시가총액:
$173.76M
수익:
$163.78M
순이익/손실:
$25.88M
주가수익비율:
4.8308
EPS:
0.65
순현금흐름:
$-28.66M
1주 성능:
+6.08%
1개월 성능:
-1.26%
6개월 성능:
-42.07%
1년 성능:
-56.75%
1일 변동 폭
$3.01
$3.2578
1주일 범위
$2.8838
$3.57
52주 변동 폭
$2.645
$8.275
Voyager Therapeutics Inc Stock (VYGR) Company Profile
명칭
Voyager Therapeutics Inc
전화
857-259-5340
주소
75 HAYDEN AVENUE, LEXINGTON, MA
VYGR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
3.14 | 188.14M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-02 | 개시 | Citigroup | Buy |
| 2024-11-29 | 재개 | Wedbush | Outperform |
| 2024-10-16 | 개시 | Leerink Partners | Outperform |
| 2024-03-26 | 개시 | Guggenheim | Buy |
| 2024-03-19 | 개시 | H.C. Wainwright | Buy |
| 2024-03-07 | 개시 | Citigroup | Buy |
| 2024-01-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | 개시 | Truist | Buy |
| 2023-03-10 | 개시 | Oppenheimer | Outperform |
| 2021-10-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-02-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-12-24 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-11-10 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | 개시 | The Benchmark Company | Buy |
| 2020-02-06 | 개시 | Oppenheimer | Outperform |
| 2018-11-15 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | 재개 | BTIG Research | Buy |
| 2018-09-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | 개시 | H.C. Wainwright | Buy |
| 2018-03-12 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-03-12 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-02-02 | 개시 | Morgan Stanley | Overweight |
| 2017-11-28 | 재개 | Piper Jaffray | Overweight |
| 2017-10-31 | 개시 | Robert W. Baird | Outperform |
| 2017-10-27 | 개시 | Canaccord Genuity | Buy |
| 2017-10-23 | 재확인 | Stifel | Buy |
| 2017-10-12 | 개시 | Raymond James | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-28 | 재개 | Stifel | Buy |
모두보기
Voyager Therapeutics Inc 주식(VYGR)의 최신 뉴스
Voyager Therapeutics: Strategic Restructuring and Pipeline Progress Underpin Buy Rating - TipRanks
Voyager Therapeutics Inc. stock trend forecastStock Holding Strategy Long-Term Summary Sheet - Newser
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating - TipRanks
Voyager Therapeutics Q2 Earnings: A $33.4 Million SetbackNews and Statistics - IndexBox
Voyager Therapeutics 2025 Q2 Earnings Deepened Losses Amid Extended Cash Runway - AInvest
Voyager Therapeutics Inc earnings missed by $0.04, revenue fell short of estimates - Investing.com
Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Voyager Therapeutics: Q2 Earnings Snapshot - News-Times
Voyager Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Voyager Reports Second Quarter 2025 Financial and Operating Results - The Manila Times
Voyager Therapeutics Q2 2025 Financial and Operating Results - TradingView
MarineMax (HZO) adds Odilon Almeida Jr.; two directors resign – 8-K | VYGR SEC FilingForm 8-K - Stock Titan
What is the risk reward ratio of investing in Voyager Therapeutics Inc. stockBuild your wealth with consistent stock growth - Jammu Links News
What drives Voyager Therapeutics Inc. stock priceTurbocharged investment results - Jammu Links News
Is Voyager Therapeutics Inc. stock overvalued or undervaluedFree Stock Index Interpretation - Jammu Links News
What analysts say about Voyager Therapeutics Inc. stockFree Real-Time Stock Data - Jammu Links News
What are the technical indicators suggesting about Voyager Therapeutics Inc.Outstanding investment returns - Jammu Links News
How does Voyager Therapeutics Inc. generate profit in a changing economyMarket-crushing stock picks - Jammu Links News
What are the latest earnings results for Voyager Therapeutics Inc.Maximize portfolio value with smart investment plans - Jammu Links News
What are Voyager Therapeutics Inc. company’s key revenue driversMaximize returns with effective portfolio management - Jammu Links News
What catalysts could drive Voyager Therapeutics Inc. stock higher in 2025Achieve consistent profits with disciplined trading - Jammu Links News
What are analysts’ price targets for Voyager Therapeutics Inc. in the next 12 monthsHigh-impact investment strategies - Jammu Links News
Should I hold or sell Voyager Therapeutics Inc. stock in 2025Consistent high-performance stocks - Jammu Links News
What is the dividend policy of Voyager Therapeutics Inc. stockFree Stock Market Knowledge Sharing - Jammu Links News
How many analysts rate Voyager Therapeutics Inc. as a “Buy”Wealth Building Data Feed For Every Investor - jammulinksnews.com
Is Voyager Therapeutics Inc. forming a bottoming baseStock Market Entry Timing Signals Revealed - metal.it
How does Voyager Therapeutics Inc. compare to its industry peersExpert Picks Tracker From AI Tools - Jammu Links News
Voyager Therapeutics Inc. Added to High Probability Setup ListBuy Signal Based on Chart Analysis Confirmed - metal.it
Voyager Therapeutics Inc. Tests 50 Day MA After Sharp DeclineQuick Gain Stock Watch With Indicators Reviewed - metal.it
Pattern Scan Adds Voyager Therapeutics Inc. to WatchlistMarket Entry and Exit Point Tips From Traders - metal.it
Published on: 2025-07-29 08:53:38 - metal.it
Is Voyager Therapeutics Inc. a growth stock or a value stockAI Powered Target Finder For Consistent Profits - jammulinksnews.com
Top Risks to Consider Before Buying Voyager Therapeutics Inc. StockPortfolio Diversification Stock Ideas From Experts - metal.it
What institutional investors are buying Voyager Therapeutics Inc. stockPost Market Review For 2025 - Jammu Links News
Why Voyager Therapeutics Inc. stock attracts strong analyst attentionWatchlist for Smart Swing Trading Updated - metal.it
Is Voyager Therapeutics Inc. a good long term investmentTremendous wealth creation - PrintWeekIndia
How high can Voyager Therapeutics Inc. stock price go in 2025Rapid return acceleration - Jammu Links News
Voyager Therapeutics Inc. Stock Analysis and ForecastSuperior returns - jammulinksnews.com
Voyager Therapeutics Inc (VYGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):